US Stock MarketDetailed Quotes

Corbus Pharmaceuticals (CRBP)

Watchlist
  • 10.300
  • +0.420+4.25%
Close May 1 16:00 ET
  • 10.100
  • -0.200-1.94%
Post 17:53 ET
182.69MMarket Cap-1.75P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Corbus Pharmaceuticals (CRBP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-54.31%-64.49M
-45.50%-15.92M
-11.53%-15.55M
-85.61%-16.6M
-106.11%-16.42M
-15.77%-41.79M
-82.12%-10.94M
-94.29%-13.94M
-14.64%-8.94M
47.29%-7.97M
Net income from continuing operations
-95.32%-78.54M
-115.69%-20.56M
-69.35%-23.34M
-76.67%-17.66M
-146.09%-16.98M
9.85%-40.21M
-18.80%-9.53M
-37.10%-13.78M
-13.81%-10M
61.12%-6.9M
Operating gains losses
----
----
----
----
----
----
----
----
----
572.86%6.41K
Depreciation and amortization
-60.37%233K
-63.43%49K
-67.11%50K
-64.67%53K
-46.71%81K
-8.27%588K
-9.46%134K
-0.65%152K
-5.14%150K
-16.42%152K
Other non cash items
-139.15%-229K
-93.47%13K
-56.07%47K
-396.51%-255K
-117.62%-34K
-27.33%585K
25.95%199K
-51.14%107K
-62.09%86K
-4.04%193K
Change In working capital
263.56%9.12M
250.39%3.84M
403.90%6.16M
-75.00%122K
32.71%-1M
-236.20%-5.58M
-357.84%-2.55M
-210.76%-2.03M
425.92%488K
-204.37%-1.49M
-Change in prepaid assets
151.59%634K
112.60%297K
606.87%2.66M
-491.51%-1.66M
-153.62%-659K
16.39%-1.23M
-2,435.48%-2.36M
22.71%-524K
407.73%424K
318.99%1.23M
-Change in payables and accrued expense
325.57%9.04M
5,760.00%3.68M
365.43%3.65M
891.24%1.92M
92.47%-208K
-166.15%-4.01M
-103.27%-65K
-131.82%-1.37M
43.70%194K
-629.01%-2.76M
-Change in other current assets
-7.97%1.05M
12.70%275K
13.62%267K
13.16%258K
-42.30%251K
49.48%1.14M
19.61%244K
7.31%235K
32.32%228K
157.86%435K
-Change in other current liabilities
-8.44%-1.61M
-12.13%-416K
-11.51%-407K
-11.45%-399K
0.78%-384K
-17.63%-1.48M
66.49%-371K
82.00%-365K
-12.13%-358K
-117.63%-387K
Cash from discontinued investing activities
Operating cash flow
-54.31%-64.49M
-45.50%-15.92M
-11.53%-15.55M
-85.61%-16.6M
-106.11%-16.42M
-15.77%-41.79M
-82.12%-10.94M
-94.29%-13.94M
-14.64%-8.94M
47.29%-7.97M
Investing cash flow
Cash flow from continuing investing activities
98.65%-1.64M
-754.58%-57.15M
227.81%19.64M
207.93%17.74M
118.45%18.12M
-440.36%-121.31M
-15.96%8.73M
-241.00%-15.37M
-286.65%-16.44M
-1,870.11%-98.24M
Net PPE purchase and sale
---7K
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
98.65%-1.63M
-754.50%-57.14M
227.81%19.64M
207.93%17.74M
118.45%18.12M
-440.36%-121.31M
-15.96%8.73M
-241.00%-15.37M
-286.65%-16.44M
-1,870.11%-98.24M
Cash from discontinued investing activities
Investing cash flow
98.65%-1.64M
-754.58%-57.15M
227.81%19.64M
207.93%17.74M
118.45%18.12M
-440.36%-121.31M
-15.96%8.73M
-241.00%-15.37M
-286.65%-16.44M
-1,870.11%-98.24M
Financing cash flow
Cash flow from continuing financing activities
-53.52%77.43M
573,753.85%74.58M
-88.62%2.85M
0
0
6,004.93%166.58M
99.32%-13K
3,150.43%25.04M
194,042.14%34.97M
94,412.01%106.58M
Net issuance payments of debt
--0
--0
--0
--0
--0
-438.62%-15.48M
--0
-1,370.58%-10.9M
-1,391.44%-2.27M
-1,443.99%-2.32M
Net common stock issuance
-57.47%77.43M
573,753.85%74.58M
-92.07%2.85M
--0
--0
343,405.66%182.06M
82.43%-13K
45,026.25%35.94M
21,807.80%37.23M
293,776.84%108.9M
Net other financing activities
----
----
----
----
----
----
----
----
----
---6.69M
Cash from discontinued financing activities
Financing cash flow
-53.52%77.43M
573,753.85%74.58M
-88.62%2.85M
--0
--0
6,004.93%166.58M
99.32%-13K
3,150.43%25.04M
194,042.14%34.97M
94,412.01%106.58M
Net cash flow
Beginning cash position
24.14%17.87M
37.63%27.65M
-14.95%20.71M
32.47%19.57M
24.14%17.87M
-18.55%14.39M
68.58%20.09M
170.05%24.36M
84.79%14.77M
-18.55%14.39M
Current changes in cash
225.10%11.29M
167.82%1.51M
262.77%6.94M
-88.06%1.14M
349.08%1.7M
205.95%3.47M
-189.90%-2.23M
-247.00%-4.26M
835.59%9.58M
103.92%379K
End cash Position
63.21%29.16M
63.21%29.16M
37.63%27.65M
-14.95%20.71M
32.47%19.57M
24.14%17.87M
24.14%17.87M
68.58%20.09M
170.05%24.36M
84.79%14.77M
Free cash flow
-54.32%-64.5M
-45.57%-15.93M
-11.53%-15.55M
-85.61%-16.6M
-106.11%-16.42M
-15.77%-41.79M
-82.12%-10.94M
-94.29%-13.94M
-14.64%-8.94M
47.29%-7.97M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -54.31%-64.49M-45.50%-15.92M-11.53%-15.55M-85.61%-16.6M-106.11%-16.42M-15.77%-41.79M-82.12%-10.94M-94.29%-13.94M-14.64%-8.94M47.29%-7.97M
Net income from continuing operations -95.32%-78.54M-115.69%-20.56M-69.35%-23.34M-76.67%-17.66M-146.09%-16.98M9.85%-40.21M-18.80%-9.53M-37.10%-13.78M-13.81%-10M61.12%-6.9M
Operating gains losses ------------------------------------572.86%6.41K
Depreciation and amortization -60.37%233K-63.43%49K-67.11%50K-64.67%53K-46.71%81K-8.27%588K-9.46%134K-0.65%152K-5.14%150K-16.42%152K
Other non cash items -139.15%-229K-93.47%13K-56.07%47K-396.51%-255K-117.62%-34K-27.33%585K25.95%199K-51.14%107K-62.09%86K-4.04%193K
Change In working capital 263.56%9.12M250.39%3.84M403.90%6.16M-75.00%122K32.71%-1M-236.20%-5.58M-357.84%-2.55M-210.76%-2.03M425.92%488K-204.37%-1.49M
-Change in prepaid assets 151.59%634K112.60%297K606.87%2.66M-491.51%-1.66M-153.62%-659K16.39%-1.23M-2,435.48%-2.36M22.71%-524K407.73%424K318.99%1.23M
-Change in payables and accrued expense 325.57%9.04M5,760.00%3.68M365.43%3.65M891.24%1.92M92.47%-208K-166.15%-4.01M-103.27%-65K-131.82%-1.37M43.70%194K-629.01%-2.76M
-Change in other current assets -7.97%1.05M12.70%275K13.62%267K13.16%258K-42.30%251K49.48%1.14M19.61%244K7.31%235K32.32%228K157.86%435K
-Change in other current liabilities -8.44%-1.61M-12.13%-416K-11.51%-407K-11.45%-399K0.78%-384K-17.63%-1.48M66.49%-371K82.00%-365K-12.13%-358K-117.63%-387K
Cash from discontinued investing activities
Operating cash flow -54.31%-64.49M-45.50%-15.92M-11.53%-15.55M-85.61%-16.6M-106.11%-16.42M-15.77%-41.79M-82.12%-10.94M-94.29%-13.94M-14.64%-8.94M47.29%-7.97M
Investing cash flow
Cash flow from continuing investing activities 98.65%-1.64M-754.58%-57.15M227.81%19.64M207.93%17.74M118.45%18.12M-440.36%-121.31M-15.96%8.73M-241.00%-15.37M-286.65%-16.44M-1,870.11%-98.24M
Net PPE purchase and sale ---7K------------------0----------------
Net investment purchase and sale 98.65%-1.63M-754.50%-57.14M227.81%19.64M207.93%17.74M118.45%18.12M-440.36%-121.31M-15.96%8.73M-241.00%-15.37M-286.65%-16.44M-1,870.11%-98.24M
Cash from discontinued investing activities
Investing cash flow 98.65%-1.64M-754.58%-57.15M227.81%19.64M207.93%17.74M118.45%18.12M-440.36%-121.31M-15.96%8.73M-241.00%-15.37M-286.65%-16.44M-1,870.11%-98.24M
Financing cash flow
Cash flow from continuing financing activities -53.52%77.43M573,753.85%74.58M-88.62%2.85M006,004.93%166.58M99.32%-13K3,150.43%25.04M194,042.14%34.97M94,412.01%106.58M
Net issuance payments of debt --0--0--0--0--0-438.62%-15.48M--0-1,370.58%-10.9M-1,391.44%-2.27M-1,443.99%-2.32M
Net common stock issuance -57.47%77.43M573,753.85%74.58M-92.07%2.85M--0--0343,405.66%182.06M82.43%-13K45,026.25%35.94M21,807.80%37.23M293,776.84%108.9M
Net other financing activities ---------------------------------------6.69M
Cash from discontinued financing activities
Financing cash flow -53.52%77.43M573,753.85%74.58M-88.62%2.85M--0--06,004.93%166.58M99.32%-13K3,150.43%25.04M194,042.14%34.97M94,412.01%106.58M
Net cash flow
Beginning cash position 24.14%17.87M37.63%27.65M-14.95%20.71M32.47%19.57M24.14%17.87M-18.55%14.39M68.58%20.09M170.05%24.36M84.79%14.77M-18.55%14.39M
Current changes in cash 225.10%11.29M167.82%1.51M262.77%6.94M-88.06%1.14M349.08%1.7M205.95%3.47M-189.90%-2.23M-247.00%-4.26M835.59%9.58M103.92%379K
End cash Position 63.21%29.16M63.21%29.16M37.63%27.65M-14.95%20.71M32.47%19.57M24.14%17.87M24.14%17.87M68.58%20.09M170.05%24.36M84.79%14.77M
Free cash flow -54.32%-64.5M-45.57%-15.93M-11.53%-15.55M-85.61%-16.6M-106.11%-16.42M-15.77%-41.79M-82.12%-10.94M-94.29%-13.94M-14.64%-8.94M47.29%-7.97M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -